Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials
The Oncologist · 2024
DOI: 10.1093/oncolo/oyad237 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Oncologist, 2024. Verfasst von Morgan R L Lichtenstein und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: COVID-19, Telemedicine, Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, National Cancer Institute.
Abstract (Originalsprache)
Background
Since the onset of COVID-19, oncology practices across the US have integrated telemedicine (TM) and remote patient monitoring (RPM) into routine care and clinical trials. The extent of provider experience and comfort with TM/RPM in treatment trials, however, is unknown. We surveyed oncology researchers to assess experience and comfort with TM/RPM.
Methods
Between April 10 and June 1, 2022, we distributed email surveys to US-based members of the American Society of Clinical Oncology (ASCO) whose member records indicated interest or specialization in clinical research. We collected respondent demographic data, clinical trial experience, workplace characteristics, and comfort and experience with TM/RPM use across trial components in phase I and phase II/III trials. TM/RPM was defined as clinical trial-related healthcare and monitoring for patients geographically separated from trial site.
Results
There were 141 surveys analyzed (5.1% response rate). Ninety percent of respondents had been Principal Investigators, 98% practiced in a norural site. Most respondents had enrolled patients in phase I (82%) and phase II/III trials (99%). Across all phases and trial components, there was a higher frequency of researcher comfort compared to experience. Regarding remote care in treatment trials, 75% reported using TM, RPM, or both. Among these individuals, 62% had never provided remote care to trial patients before the pandemic.
Conclusion
COVID-19 spurred the rise of TM/RPM in cancer treatment trials, and some TM/RPM use continues in this context. Among oncology researchers, higher levels of comfort compared with real-world experience with TM/RPM reveal opportunities for expanding TM/RPM policies and guidelines in oncology research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
- Center for Research and Analytics, American Society of Clinical Oncology, Alexandria, VA, USA.
- Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD, USA.
- Department of Medicine, Duke Cancer Institute and Medical Oncology, Duke University Medical Center, and Hematology-Oncology, Durham VA Medical Center, Durham, NC, USA.
- NorCal CarciNET Community, San Francisco, CA, USA.
- Department of Medicine, University of Rochester Medical Center, Rochester, NY, USA.
ORCID-Profile: Laura A Levit, Allison Magnuson
Förderung
- NCI NIH HHS
- National Cancer Institute
Zitieren
APA
Lichtenstein, M. R. L., Levit, L. A., Schenkel, C., Kirkwood, K., Fashoyin-Aje, L. A., Bruinooge, S. S., Kelley, M. J., Mailman, J. A., Magnuson, A., Mirda, D. P., Natesan, D., & Hershman, D. L. (2024). Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials. The Oncologist. https://doi.org/10.1093/oncolo/oyad237
Vancouver
Lichtenstein MRL, Levit LA, Schenkel C, Kirkwood K, Fashoyin-Aje LA, Bruinooge SS, et al. Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials. The Oncologist. 2024. doi:10.1093/oncolo/oyad237
BibTeX
@article{Lichtenstein2024,
author = {Lichtenstein, Morgan R L and Levit, Laura A and Schenkel, Caroline and Kirkwood, Kelsey and Fashoyin-Aje, Lola A and Bruinooge, Suanna S and Kelley, Michael J and Mailman, Josh A and Magnuson, Allison and Mirda, Daniel P and Natesan, Divya and Hershman, Dawn L},
title = {Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials},
journal = {The Oncologist},
year = {2024},
doi = {10.1093/oncolo/oyad237}
}
EUVIMED